We carried out a study describing the extent and patterns of use of antihypertensive drugs and identifying common diseases in a cohort of workers. The population was monitored on a yearly basis by a questionnaire to assess the use of antihypertensive drugs. The extent and causes of absenteeism for medical reasons and diagnoses of cancer were taken from systematic records from the company. Four cross-sectional analyses covering a period of 5 years are presented. For the 17,244 respondants in 1990 -12,731 men aged 41 to 51 years and 4,513 women aged 36 to 51 years-the prevalence of antihypertensive drug use was 6.5%, and 5 years later, antihypertensive drug use had doubled. This increase involved calcium channel inhibitors in particular. In all analyses, excess absenteeism for all health-related disorders was observed among those treated with antihypertensive drugs compared with the remainder of the population, who were almost all nonhypertensive: 44% v 34% (P < < .000) in 1990, 42% v 34% (P < < .000) in 1991, 41% v 34% (P < < .000) in 1993, and 37% v 29% (P < < .000) in 1994. A ntihypertensive therapy is a long-term treatment often used for individuals who continue to work. The effects of exposure to antihypertensive agents are not fully understood and there has been no complete study of the health disorders associated with the use of these drugs. Antihypertensive medications have many severe side effects, and are thus of considerable interest as potential causes of absenteeism caused by ill health. We carried out a follow-up study describing the use of antihypertensive drugs and the extent and causes of health-related absenteeism associated with exposure to these drugs. The study was conducted in France, using a cohort of workers employed by a company that maintained complete health records. Four crosssectional analyses were performed over a period of 5 years. Preliminary results over a 4-year period on the prevalence and incidence of cancers are also presented.
A ntihypertensive therapy is a long-term treatment often used for individuals who continue to work. The effects of exposure to antihypertensive agents are not fully understood and there has been no complete study of the health disorders associated with the use of these drugs. Antihypertensive medications have many severe side effects, and are thus of considerable interest as potential causes of absenteeism caused by ill health. We carried out a follow-up study describing the use of antihypertensive drugs and the extent and causes of health-related absenteeism associated with exposure to these drugs. The study was conducted in France, using a cohort of workers employed by a company that maintained complete health records. Four crosssectional analyses were performed over a period of 5 years. Preliminary results over a 4-year period on the prevalence and incidence of cancers are also presented.
MATERIALS AND METHODS
The study population consisted of workers at Electricité de France-Gaz de France (EDF-GDF) who agreed to participate in a study in 1989 by responding to an initial postal questionnaire sent to all members of the company aged 40 to 50 years (for men) or 35 to 50 years (for women). Follow-up questionnaires were sent to participants every year to update the information. Details of the prescription drugs used were collected from the questionnaire. Participants were asked to copy, from the prescription or packaging, the names of all drugs taken during the year.
Information on health-related absences and cancer was collected from existing medical records kept by the company. The records of health-related absences were virtually complete. In addition, for the majority of absentees, the existing medical records also included diagnosis by a company physician of the illness responsible for the absence. Records of absences with diagnoses were considered to be complete for all major health events. Absences were coded according to a list of 174 diagnoses, obtained by grouping items from the International Classification of Diseases, 9th revision. 1 Diagnoses of cancer were taken from the company's cancer registry. Absences were also categorized as illnesses (absence less than 1 year), long-term illnesses (absence longer than 1 year), work-related accidents, non-work-related accidents, and occupational diseases. Any person with one or more absences in the year was considered as a case; any person with one or more absences in the year caused by a given diagnosed condition or category of illness was classified as a case of absence with a given diagnosis. Prevalence was thus defined as the number of workers with a particular condition during a given year of study rather than the total number of occurrences of that condition in the population studied.
The annual prevalence of absences related to health disorders and the main causes of absence were analyzed according to whether an individual had been exposed to antihypertensive drugs during that year. The annual prevalence ratios were used to compare the prevalence of absence (or prevalence of absence with a given diagnosis) for subjects exposed to antihypertensive agents during a given year with the remainder of the study population. Crude and adjusted treated/untreated prevalence ratios and 95% confidence intervals were calculated using the MantelHaenszel method. 2 The prevalence of absences was also compared in these groups using the 2 test. Four cross-sectional analyses over a period of 5 years were carried out (exposure and outcome in 1990, 1991, 1993, and 1994) . Each cross-sectional analysis of absenteeism included all respondants who had not retired before the end of that year.
RESULTS
This pharmacoepidemiologic study begun in 1990, when questions about drug use were first included in the follow-up questionnaire sent to workers who had already agreed to participate in a cohort. Of the 17,244 respondants in 1990, 12,731 were men aged 41 to 51 years (40.5% of initial target population) and 4513 were women aged 36 to 51 years (32% of the initial target population). The prevalence of antihypertensive treatment in 1990 was then 6.8%. It reached 12.2% 5 years later, in the 15,274 respondants to the questionnaire. Eighty-six percent of those treated with antihypertensive drugs in 1990 and 75% of those treated in 1994 were reported to be hypertensive, whereas the proportion of untreated subjects with hypertension was 3% for each of the 2 years. Initially most subjects treated with antihypertensive agents were given ␤-blockers (3.9%), angiotensin converting enzyme inhibitors (2.2%), calcium-channel inhibitors (1.1%), or diuretics (0.9%). For the same age range, 41 to 51 years of age in 1990, more men than women were treated with antihypertensive drugs, but the increase in use of this treatment was similar for both genders during the 5 years (7.4% in 1990 v 13.1% in 1994 for men, and 6.3% in 1990 v 12.6% in 1994 for women). The use of antihypertensive drugs increased by 80% during the 5-year period of the study. The largest increase during this time, 140%, was recorded for calcium-channel inhibitors. There was a 100% increase in the use of diuretics, a 90% increase for angiotensin converting enzyme inhibitors, and a 60% increase for ␤-blockers. Despite the observed changes in the use of the various pharmacologic classes of antihypertensive drugs, the ranking of pharmacologic preferences was the same in 1994 as in 1990 ( Figure 1 ).
The annual prevalence of health-related absenteeism was consistently higher in those treated with antihypertensive drugs than in the rest of the study population ( Figure 2 ): 44% v 34% (P Ͻ .000) in 1990; 42% v 34% (P Ͻ .000) in 1991; 41% v 34% (P Ͻ .000) in 1993; and 37% v 29% in 1994 (P Ͻ .000).
No such excess absenteeism was observed in the study population for those given treatment to lower plasma lipid concentration. In 1990 the annual rate of absenteeism was 35.6% in the 1333 subjects treated for hyperlipidemia and 34.9% for untreated subjects; in 1994, the rate was 30.1% for the 1664 individuals treated for hyperlipidemia v 29.8% for those not treated.
Gender and professional status were clearly linked to outcome in the population studied. There was more absenteeism in women than in men (51% v 29%); the upper professional category had the lowest rate of absenteeism (18% for executives, 36% for supervisors, and 50% for workers). The proportion of the study population treated with antihypertensive drugs increased with age for both men and women. Taking these factors into account by calculating the prevalence ratios over strata of gender, age, and professional status using the Mantel-Haenszel approach did not affect the treated/untreated prevalence ratios of health-related absenteeism, which remained 20% to 40% higher in those treated with antihypertensive Adding factors such as tobacco and alcohol use, known to cause health problems, to the analysis did not affect overall health-related absenteeism in the treated population compared with the untreated. The prevalence of absenteeism in those treated with antihypertensive agents was 20% to 40% higher than for the rest of the population according to the year of the study (Table 1) .
DISCUSSION
The working population studied was described over a period of 5 years by medical reports, mainly the company's records of absenteeism for medical reasons; health-related absenteeism probably does not cover either minor health problems or those well controlled by treatment. Thus health-related absenteeism gives a general view of ill health, its extent, and its common causes. Our study focused on whether the subjects were treated by antihypertensive drugs. In four crosssectional studies of treatment and absenteeism during individual years, assessed independently, an excess of absenteeism was observed in those treated with antihypertensive drugs. This association held for the duration of the study, during which the proportion of subjects treated with antihypertensive drugs doubled. This excess was observed for health-related absenteeism as a whole and for absenteeism for disease, to which most absences belong.
Are the Results Valid?
The volunteer status of the population studied introduced an element of selection. The upper professional category and men 3 were both overrepresented in our volunteer population, and both professional status and gender were found to affect absenteeism. Taking these factors, as well as age, into account did not affect the association between antihypertensive treatment and health-related absenteeism. However, the response rate was low, so it is possible that the relationship between antihypertensive treatment and illness (or health-related absenteeism) was different for those who participated and for those who were eligible for the study but did not participate. This would result in a selection bias, which would not be correctable by analysis. When we compared health-related absenteeism in those treated with drugs to lower plasma lipid concentration with that of those not treated by these drugs, there was no excess absenteeism for antihyperlipidemia treatment in any of the cross-sectional studies. This suggests that there was no such selection bias, otherwise it would have to be accepted that there was a selection bias on the basis of the type of treatment, which seems highly unlikely.
How Can This Excess of Absenteeism Be Explained?
We analyzed absenteeism in terms of its causes. Absenteeism associated with signs or symptoms of arterial hypertension, or diseases commonly associated with hypertension, such as angina pectoris, acute myocardial infarction, and diabetes, was more frequent in subjects treated with antihypertensive agents than in untreated individuals. Annual health-related absenteeism due to all these causes, and a small number of strokes, accounted for 2% of all health-related absenteeism in 1990 and 3% 5 years later. Over the same period time, health-related absenteeism in the population treated with antihypertensive drugs rose from 8.6% in 1990 to 15% in 1994. Clearly, cardiovascular health problems and symptomatic hypertension, which are very frequent in the treated population, cannot entirely account for this excess absenteeism for medical reasons. Antihypertensive drug therapy frequently causes adverse effects. A recent report found side effects in more than 90% of cases. 4 Most people who discontinued treatment, having suffered side effects, reported that the side effects had had an impact on their working life. 5 The high prevalence of absenteeism in subjects treated with antihypertensive drugs in this study is therefore consistent with the high frequency and severity of side effects caused by this medication.
Of the most common causes of absenteeism (16 health disorders with an annual prevalence Ͼ 100), fatigue, depression, and other psychiatric disorders occurred more often, in each of the cross-sectional studies, in individuals treated with antihypertensive drugs, although this was not statistically significant. Fatigue and reduced work capacity were the most commonly reported adverse effects for ␤-blockers, the pharmacologic class of antihypertensive agent found most frequently throughout the study, with an occurrence rate of at least 20%. Psychosis, depression, and other central nervous system disorders were reported in several patients given ␤-blockers as a regular therapy who had no previous history of psychiatric illness. 6 Psychiatric disorders were also observed in individuals given calcium channel inhibitors. 7, 8 The report of the Stroke Association (UK) on discontinuation of antihypertensive treatment stated that most of those suffering side effects endured severe side effects and that more than half of them experienced tiredness and lethargy. 5 Our results are consistent with these reports.
Labeling subjects as hypertensive has also been reported to be associated with an increase in absenteeism from work. 9 The problems associated with diagnostic labeling for hypercholesterolemia have not been studied in detail, but adverse health responses to diagnosis have been reported in case studies. 10 In our study there was excess absenteeism in those treated with antihypertensive drugs but not in those treated with drugs to lower plasma lipid content. Thus, it is unlikely that labeling subjects as hypertensive was involved in the absenteeism of individuals treated with antihypertensive drugs.
In conclusion, our results suggest that antihypertensive drugs may affect the incidence of common health disorders and their impact on work. Given the significant increase in the use of antihypertensive drugs, particularly of new drugs, and the long-term nature of antihypertensive treatments, this may have a major effect on the absenteeism and working life of hypertensive individuals.
